[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351903-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351903-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","liquid-metal-nanotransformers-for-drug-resistant-pan-cancer-therapy-in-patient-derived-organoids-research-article","Liquid Metal Nanotransformers for Drug-Resistant Pan-Cancer Therapy in Patient-Derived Organoids - Research Article","","Drug resistance remains a major obstacle in cancer therapy, and direct mechanical disruption of cellular structures offers a promising strategy for overcoming it, highlighting the urgent clinical need for an effective and universal pan-cancer treatment. Here, a cryo-responsive liquid metal (LM) nanotransformer platform is developed. It undergoes dramatic deformation under freezing, physically disrupting lysosomal membranes and inducing potent cytotoxicity, particularly against drug-resistant tumors, thus offering a broadly applicable pan-cancer treatment. To enhance deformation efficiency of LM transformers, bismuth (Bi) is incorporated into gallium (Ga) to form biphasic Bi-Ga alloy particles.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/liquid-metal-nanotransformers-for-drug-resistant-pan-cancer-therapy-in-patient-derived-organoids-research-article/351903/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/liquid-metal-nanotransformers-for-drug-resistant-pan-cancer-therapy-in-patient-derived-organoids-research-article/351903.png","ImageObject",300,407,{"name":42,"@type":43},"Kurz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the core strategy of the LM nanotransformer platform in this study?","Question",{"text":63,"@type":64},"The platform is cryo-responsive: freezing triggers dramatic liquid metal deformation that physically disrupts lysosomal membranes, producing cytotoxicity against drug-resistant tumors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is bismuth incorporated into gallium (Bi-Ga alloy)?",{"text":68,"@type":64},"Bi-Ga biphasic alloy particles reduce Ga supercooling and promote crystallization during freezing, improving LM deformation efficiency.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the study evaluate therapeutic effects across cancers?",{"text":72,"@type":64},"It tests 11 patient-derived tumor organoid models spanning lung, colorectal, and ovarian cancers, showing significant anti-tumor effects and strongest efficacy when Bi-Ga is combined with chemotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351903,1790502530,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nLiquid Metal Nanotransformers for Drug-Resistant Pan-Cancer Therapy in Patient-Derived Organoids  \nXiaojie Yuan1, 2 Cheng Hao3  Huiping Li4   \n Xuelin Wang3   Zhongyao Chen4, 5  Shuo Wang6  Weining Gao7  Ziyi Chen8  Runyang Li4 Lei Zhang8, 9  Qiongqiong Zhang9  Ke Zhang8, 9  Mei Yu10  Qian Liu10  Jingxuan Wang11  Simpkins Fiona12  Jing Liu13  Qiang Liu7  Peng Liu1, 4   Yawei Hu1, 9, 12   \n1 Changping National Laboratory, Beijing, China  2 Department of Chemical Engineering, Tsinghua University, Beijing, China  3 School of Engineering Medicine, Beihang University, Beijing, China  4 School of Biomedical Engineering, Tsinghua University, Beijing, China  5 Center of International Innovation For Technology and Science, Shenzhen, China  6 Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China  7 Peking University International Hospital, Beijing, China  8 School of Clinical Medicine, Tsinghua University (Beijing Tsinghua Changgung Hospital), Beijing, China  9 Department of Obstetrics and Gynecology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China  10 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Obstetric & Gynecologic Diseases, Beijing, China  11 School of Basic Medical Sciences, Tsinghua University, Beijing, China  12 Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, USA  13 State Key Laboratory of Cryogenic Science and Technology, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China  \nCorrespondence: Xuelin Wang ([wangxuelin@buaa.edu.cn](wangxuelin@buaa.edu.cn))  Qiang Liu (drlaoliu@sina.com)  Peng Liu (pliu@mail.tsinghua.edu.cn)  Yawei Hu ([huyawei@cpl.ac.cn](huyawei@cpl.ac.cn))  \nReceived: 22 October 2025  Revised: 18 March 2026  Accepted: 31 March 2026  \nKeywords: cryotherapy | drug-resistance | liquid metal nanotransformer | pan-cancer | patient-derived organoids  \nABSTRACT  \nDrug resistance remains a major obstacle in cancer therapy, and direct mechanical disruption of cellular structures offers a promising strategy for overcoming it, highlighting the urgent clinical need for an effective and universal pan-cancer treatment. Here, a cryo-responsive liquid metal (LM) nanotransformer platform is developed. It undergoes dramatic deformation under freezing, physically disrupting lysosomal membranes and inducing potent cytotoxicity, particularly against drug-resistant tumors, thus offering a broadly applicable pan-cancer treatment. To enhance deformation efficiency of LM transformers, bismuth (Bi) is incorporated into gallium (Ga) to form biphasic Bi-Ga alloy particles, which reduces Ga supercooling and promotes crystallization during freezing. The biosafety of LM particles is evaluated across multiple organoid models upon maximum contact. Based on 11 tumor organoid models including lung, colorectal, and ovarian cancers, the significant anti-tumor effects of LMassisted cryotherapy are demonstrated, particularly Bi-Ga combined with chemotherapy illustrating the strongest anti-tumor efficacy. Transcriptomic analysis reveals LM anti-tumor mechanism on multiple cancers with altering gene expression related to necroptosis, metabolic regulation, and cellular stress. In addition, tumors receiving LM cryo-treatment exhibited hallmark features of immunogenic cell death. In immune-competent drug-resistant lung organoids, Bi-Ga cryo-treatment modulates tumor microenvironment and enhances immunogenicity. Collectively, this study establishes a universal LM nanotransformer-enabled pan-cancer strategy, offering a clinically viable and drug-free approach for overcoming drug resistance.  \n\n| [Correction added on 14 Apr","cbCaifz9tQgqFY5h","https://ap.wps.com/l/cbCaifz9tQgqFY5h","pdf",12256064,"English","# Introduction\n## Drug resistance challenges in cancer therapy\n## Nanotransformers and physical strategies against resistance\n## Immunogenic cell death and tumor immune modulation","[{\"question\":\"What is the core strategy of the LM nanotransformer platform in this study?\",\"answer\":\"The platform is cryo-responsive: freezing triggers dramatic liquid metal deformation that physically disrupts lysosomal membranes, producing cytotoxicity against drug-resistant tumors.\"},{\"question\":\"Why is bismuth incorporated into gallium (Bi-Ga alloy)?\",\"answer\":\"Bi-Ga biphasic alloy particles reduce Ga supercooling and promote crystallization during freezing, improving LM deformation efficiency.\"},{\"question\":\"How does the study evaluate therapeutic effects across cancers?\",\"answer\":\"It tests 11 patient-derived tumor organoid models spanning lung, colorectal, and ovarian cancers, showing significant anti-tumor effects and strongest efficacy when Bi-Ga is combined with chemotherapy.\"}]","Liquid Metal Nanotransformers for Drug-Resistant Pan-Cancer Therapy in Patient-Derived Organoids - Research Article | PDF",1790096469,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e03c2bd09e4fab2844576ea8cd25a23d.webp",983,1283,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c33ef3bcdf19be7e65f9081650f02eda.webp",982,1281,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/225c0d6ad58c9963f7d88b268412366a.webp",981,1280,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ee6092318efc2dfb47dfe5805087bdc.webp",980,1279]